| 13.68 0.83 (6.46%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 17.95 | 1-year : | 20.96 |
| Resists | First : | 15.36 | Second : | 17.95 |
| Pivot price | 8.09  |
|||
| Supports | First : | 8.8 |
Second : | 4.75 |
| MAs | MA(5) : | 12.3 |
MA(20) : | 7.4 |
| MA(100) : | 5 |
MA(250) : | 0 | |
| MACD | MACD : | 1.9 |
Signal : | 1.1 |
| %K %D | K(14,3) : | 82.9  |
D(3) : | 85.4 |
| RSI | RSI(14): 81 |
|||
| 52-week | High : | 15.36 | Low : | 3.43 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CV ] has closed below upper band by 6.7%. Bollinger Bands are 922.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for {EMPTY} days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 14.29 - 14.34 | 14.34 - 14.39 |
| Low: | 11.57 - 11.63 | 11.63 - 11.68 |
| Close: | 13.56 - 13.67 | 13.67 - 13.77 |
M
Mon, 15 Dec 2025
CapsoVision (NASDAQ:CV) Trading Up 7.3% - Here's Why - MarketBeat
Fri, 12 Dec 2025
CapsoVision (NASDAQ:CV) Shares Gap Down - Should You Sell? - MarketBeat
Thu, 11 Dec 2025
CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook - ts2.tech
Wed, 10 Dec 2025
What Sparked CapsoVision's (CV) 53% Surge In After-Hours Trading? - Benzinga
Wed, 12 Nov 2025
CapsoVision Inc (CV) Q3 2025 Earnings Report Preview: What to Expect - Yahoo Finance
Mon, 10 Nov 2025
CapsoVision Seeks FDA Breakthrough Status for CapsoCam - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 47 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 40.6 (%) |
| Held by Institutions | 0.8 (%) |
| Shares Short | 79 (K) |
| Shares Short P.Month | 38 (K) |
| EPS | -0.48 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.43 |
| Profit Margin | -172.4 % |
| Operating Margin | -226.7 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 19.2 % |
| Gross Profit (p.s.) | 0.14 |
| Sales Per Share | 0.27 |
| EBITDA (p.s.) | -0.48 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -21 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -28.51 |
| PEG Ratio | 0 |
| Price to Book value | 31.09 |
| Price to Sales | 48.95 |
| Price to Cash Flow | -31.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|